Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)

Clinical trial NCT07642557 · RECRUITING

Trial details

NCT number: NCT07642557
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Spontaneous Urticaria

Start date: 2026-08-04
Primary completion: 2029-05-31
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.